Results 281 to 290 of about 109,434 (328)
ABSTRACT Introduction Although clinical experience of a triple‐secured, plasma‐derived, von Willebrand factor (pdVWF), almost devoid of Factor VIII (FVIII) in adults with von Willebrand disease (VWD), is widely reported, its use in children is less documented.
Jenny Goudemand +10 more
wiley +1 more source
ABSTRACT Aim To characterise and evaluate mucoadhesive strength and antibacterial properties of a nanotechnological formulation for endodontic disinfection based on biodegradable nanoparticles dispersed in a thermosensitive gel containing calcium hydroxide (Ca(OH)2‐NPs‐gel).
Xavier Roig‐Soriano +9 more
wiley +1 more source
Mugwort sensitization and asthma as predictors of food-induced anaphylactic shock in children: a retrospective study in Northern China. [PDF]
Zhou Z, Zhang J, Dai N, Li Z.
europepmc +1 more source
Latex allergy: a challenge for anaesthetists [PDF]
Demaegd, J, Herregods, Luc, Soetens, F
core +1 more source
ABSTRACT Aims To explore parents’ experiences of parenting adolescents with food allergies. Design An interpretive descriptive qualitative study. Methods Semi‐structured interviews were conducted between November 2023 and March 2024 with 11 parents of adolescents with food allergies aged 12–16 years, 8 mothers and 3 fathers. Reflexive thematic analysis
Meg O’ Sullivan +4 more
wiley +1 more source
Online food allergy and anaphylaxis education for school personnel is effective and scalable: experience with the allergyaware e-learning portal from 2015 to 2022. [PDF]
Sharma B +5 more
europepmc +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source

